Skip to main content

Advertisement

Table 1 Distribution of the clinical status of patients in this study

From: microRNA expression pattern as an ancillary prognostic signature for radiotherapy

  Before radiation
Screening set (n = 8) Training set (n = 38)
Poor response Response P Poor response Response P
N Mean SD N Mean SD N Mean SD N Mean SD
Typeb
 H&N 2    2    1 8    17    0.69
 Colorectal 2    2     5    8    
Agea 4 69.75 16.24 4 62 16.81 0.52 13 61.54 15.03 25 61.08 15.21 0.93
Sexb
 Female 1    1    1 6    13    0.732
 Male 3    3     7    12    
Stageb
 I 1    1    0.23 1    4    0.111
 II 0    2     0    6    
 III 3    1     4    8    
 IV 0    0     8    7    
Total dosagea (Gy) 3 63.87 11.68 4 60.25 11.37 0.69 13 66.18 7.58 24 63.61 9.29 0.398
Chemotherapyb 4    4    1 13    25    0.728
  1. Each groups were well matched for age, gender. Mean, average of each samples
  2. SD standard deviation, M male, F female
  3. *P value < 0.05
  4. aIndependent samples test
  5. bPearson Chi Square
  Before radiation
Testing (n = 24)
Poor response Response P
N Mean SD N Mean SD
Typeb
 H&N 1    10    0.902
 Colorectal 1    12    
Agea 2 69.5 9.19 22 54.45 11.99 0.1
Sexb
 Female 2    15    0.343
 Male 0    7    
Stageb
 I 0    3    0.081
 II 0    6    
 III 0    8    
 IV 2    5    
Total dosagea (Gy) 2 60.2 13.86 22 58.03 14.7 0.843
Chemotherapyb 2    22    0.577
  1. Each groups were well matched for age, gender. Mean, average of each samples
  2. SD standard deviation, M male, F female
  3. *P value < 0.05
  4. aIndependent samples test
  5. bPearson Chi Square
  After radiation
Screening set (n = 7) Training set (n = 31)
Poor response Response P Poor response Response P
N Mean SD N Mean SD N Mean SD N Mean SD
Typeb
 H&N 2    2    0.66 7    15    0.94
 Colorectal 1    2     3    6    
Agea 3 62.67 9.71 4 62 16.81 0.95 10 58.6 13.23 21 60.29 14.73 0.75
Sexb
 Female 1    1    0.81 5    11    0.9
 Male 2    3     5    10    
Stageb
 I 0    1    0.14 0    3    0.042*
 II 0    2     0    5    
 III 3    1     2    7    
 IV 0    0     8    6    
Total dosagea (Gy) 2 70.6 0.85 4 60.25 11.37 0.29 10 66.88 6.63 20 64.28 9.01 0.43
Chemotherapyb 3    4    0.81 10    21    0.36
  1. Each groups were well matched for age, gender. Mean, average of each samples
  2. SD standard deviation, M male, F female
  3. *P value < 0.05
  4. aIndependent samples test
  5. bPearson Chi Square
  After radiation
Testing (n = 24)  
Poor response Response P
N Mean SD N Mean SD  
Typeb
 H&N 1    10    0.902
 Colorectal 1    12    
Agea 2 69.5 9.19 22 54.45 11.99 0.1
Sexb
 Female 2    15    0.343
 Male 0    7    
Stageb
 I 0    3    0.081
 II 0    6    
 III 0    8    
 IV 2    5    
Total dosagea (Gy) 2 60.2 13.86 22 58.03 14.7 0.843
Chemotherapyb 2    22    0.577
  1. Each groups were well matched for age, gender. Mean, average of each samples
  2. SD standard deviation, M male, F female
  3. *P value < 0.05
  4. aIndependent samples test
  5. bPearson Chi Square